Alerts will be sent to your verified email
Verify Email
BLISSGVS
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Bliss GVS Pharma Limited is a global leader in Suppositories and Pessaries, offering high-quality pharmaceutical formulations at affordable prices. With a strong presence in over sixty countries, the company is rapidly growing through advancements in R&D, manufacturing, and marketing.
Bliss GVS Pharma major competitors are Syncom Formulations, Jagsonpal Pharma, Beta Drugs, Lincoln Pharma, Kwality Pharma, Novartis, Wanbury.
Market Cap of Bliss GVS Pharma is ₹1,614 Crs.
While the median market cap of its peers are ₹1,461 Crs.
Bliss GVS Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Bliss GVS Pharma is 6.36 and is ranked 5 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | ||||||||||||||||||
| Investor Presentation | Mar Jun | Mar Jun Sep Dec | Dec | |||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
